Investors
Latest News
03 Dec 2025
AD HOC
Cosmo announces breakthrough Phase III Topline results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in male hair loss, showing up to 539% relative improvement in Target-Area Hair Count vs placebo; US and EU submissions are underway
Read More14 Nov 2025
Winlevi® Receives Regulatory Approval in Brazil – Expanding Global Access to a Breakthrough Acne Treatment
Read More11 Nov 2025
Cosmo’s ESG Rating Upgraded by S&P Global; Strengthens Supplier Sustainability Oversight Engagement, and Italian Manufacturing Plant Awarded EcoVadis Bronze Medal
Read MoreUpcoming Events
Share price
More informationsManufacturing
We provide services related to the production of pharmaceutical products as: assessment of manufacturing processes, technology transfer, evaluation of pharmaceutical product stability, testing and release to the market and drafting of the necessary documentation for pharmaceutical products’ registration.
Find out more